Has Stuart Allan received payments from drug or device companies?

Yes. Drug and device makers reported $1,064 in general payments to Stuart Allan across 64 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Stuart Allan did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Stuart Allan come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Stuart Allan

Family · Munster, INNPI 1649725151

Payments from drug & device makers

$1,064in general payments, 2019–2025

Across 64 payments — averaging $16.62 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

AbbVie$409
Organogenesis Inc.$154
Paratek Pharmaceuticals, Inc.$137
Viiv Healthcare Company$77
Urgo Medical North America, LLC$57
Smith+Nephew$43
plus $188 from 7 others

What the payments were for

Food & beverage$1,064100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
AbbVie	33	$409
Organogenesis Inc.	6	$154
Paratek Pharmaceuticals, Inc.	7	$137
Viiv Healthcare Company	4	$77
Urgo Medical North America, LLC	2	$57
Smith+Nephew	2	$43
Hartmann USA, Inc.	2	$40
Convatec Inc.	2	$38
Biohaven Pharmaceuticals, Inc.	2	$28
Integra Lifesciences Corporation	1	$25
Insmed, Inc.	1	$21
Mimedx Group, Inc.	1	$21
Reprise Biomedical, Inc.	1	$15

How this compares

$1,064 in reported general payments places this provider in the 65th percentile of 4,392 family providers in Indiana.

See all family providers in Indiana →

Medicare billing

Part B allowed, 2024

$54,138

Medicare patients

243

Services billed

778

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Doxycycline Hyclate	28	$566
Cephalexin	20	$476
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim	19	$415
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav	19	$238
Amoxicillin	13	$22

Paid to pharmacies, not to this prescriber.

Other family in Munster

Monika VasicMunster$25K
Sharon HennMunster$19K
Donna WinterrowdMunster$17K
Jacquelyn AdleyMunster$16K
Tina SizemoreIndianapolis$888K
Kathalene Keller RineyEvansville$383K
Robin AndersonPortage$333K
Marla MosesIndianapolis$142K
Justin BrownFort Wayne$142K
Lacey MatheisEvansville$139K

See the full list for Indiana →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →